[HTML] sciencedirect.com

[HTML][HTML] Initial findings of the phase 1 trial of PBCAR0191, a CD19 targeted allogeneic CAR-T cell therapy

CA Jacobson, AF Herrera, LE Budde, DJ DeAngelo… - Blood, 2019 - Elsevier
Background: Adoptive engineered autologous cellular immunotherapy has had a significant
impact on the lives of some patients with advanced hematologic malignancies. However, the …
被引用次数：25 相关文章

Initial Findings of the Phase 1 Trial of PBCAR0191, a CD19 Targeted Allogeneic CAR-T Cell Therapy

CA Jacobson, AF Herrera, LE Budde, DJ DeAngelo… - 2019 - ashpublications.org
Background: Adoptive engineered autologous cellular immunotherapy has had a significant
impact on the lives of some patients with advanced hematologic malignancies. However, the …